Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.
作者信息
Baklouti Sarah, Massip Clémence, Mane Camille, Guet-Revillet Hélène, Murris Marlène, Concordet Didier, Gandia Peggy
机构信息
INTHERES, Université de Toulouse, INRA, ENVT, 23 Chemin des Capelles, BP 87614, Toulouse cedex 3, France.
CHU de Toulouse, Laboratoire de Bactériologie-Hygiène, Institut Fédératif de Biologie, 330 avenue de Grande-Bretagne, 31059, Toulouse cedex 9, France.
出版信息
J Antimicrob Chemother. 2019 Oct 1;74(10):3122-3123. doi: 10.1093/jac/dkz307.
PMID:31335940
Abstract
摘要
相似文献
1
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.评论：七种β-内酰胺类药物（包括头孢洛扎/他唑巴坦和头孢他啶/阿维巴坦）对从囊性纤维化患者中分离出的洋葱伯克霍尔德菌复合体、唐菖蒲伯克霍尔德菌及其他非发酵革兰氏阴性杆菌的体外活性
J Antimicrob Chemother. 2019 Oct 1;74(10):3122-3123. doi: 10.1093/jac/dkz307.
2
In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.七种β-内酰胺类药物（包括头孢洛扎/他唑巴坦和头孢他啶/阿维巴坦）对从囊性纤维化患者中分离出的洋葱伯克霍尔德菌复合体、唐菖蒲伯克霍尔德菌及其他非发酵革兰氏阴性杆菌的体外活性。
J Antimicrob Chemother. 2019 Feb 1;74(2):525-528. doi: 10.1093/jac/dky423.
3
"Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Complex and Cystic Fibrosis Isolates.“切换伙伴”：哌拉西林-他唑巴坦对多药耐药复杂菌和囊性纤维化分离株具有强大的联合作用。
J Clin Microbiol. 2019 Jul 26;57(8). doi: 10.1128/JCM.00181-19. Print 2019 Aug.
4
Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam.囊性纤维化患者分离的洋葱伯克霍尔德菌复合体对头孢他啶-阿维巴坦和头孢洛扎-他唑巴坦的敏感性。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00590-18. Print 2018 Sep.
5
Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli.头孢他洛酯-他唑巴坦和其他抗菌药物对洋葱伯克霍尔德菌复合体和脆弱拟杆菌的活性。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00766-17. Print 2017 Sep.
6
Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.耐哌拉西林/他唑巴坦铜绿假单胞菌对头孢他啶/阿维巴坦、头孢洛扎/他唑巴坦和碳青霉烯类药物耐药性的系统进化分析。
Int J Antimicrob Agents. 2019 Jun;53(6):774-780. doi: 10.1016/j.ijantimicag.2019.02.022. Epub 2019 Mar 2.
7
Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam.两例囊性纤维化合并先前泛耐药鲍曼不动杆菌复合体感染患者接受头孢他啶-阿维巴坦治疗后进行肺移植。
Infection. 2019 Apr;47(2):289-292. doi: 10.1007/s15010-018-1261-y. Epub 2018 Dec 19.
8
Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli.亚胺培南-雷巴他定对多药和广泛耐药洋葱伯克霍尔德菌复合群和格劳氏伯克霍尔德菌的活性。
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0133221. doi: 10.1128/AAC.01332-21. Epub 2021 Aug 9.
9
Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.战胜一种极耐药（XDR）病原体：阿维巴坦恢复了囊性纤维化患者分离出的洋葱伯克霍尔德菌复合体对头孢他啶的敏感性。
ACS Infect Dis. 2017 Jul 14;3(7):502-511. doi: 10.1021/acsinfecdis.7b00020. Epub 2017 Mar 30.
10
Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.类洋葱伯克霍尔德菌和洋葱伯克霍尔德菌感染儿童的主要方面。
Pediatr Infect Dis J. 2020 May;39(5):374-378. doi: 10.1097/INF.0000000000002587.
Zotero 插件